SOMERVILLE, Mass., & BUFFALO, N.Y.--(BUSINESS WIRE)--Nov 1, 2023--Generate:Biomedicines and Roswell Park Comprehensive Cancer Center today announced a strategic collaboration to discover and develop chimeric antigen receptor (CAR) T-cell therapies, and armoring technologies, for up ...
<p style="TEXT-ALIGN:CENTER">- Data demonstrate feasibility, tolerability, and early efficacy of mRNA/LNP in vivo CAR-M therapy in pre-clinical models of metastatic solid tumors<p style="TEXT-ALIGN:CENTER">- Proof of concept achieved for platform under the Moderna ...
<p style="TEXT-ALIGN:CENTER">Poster presentation describes the development of SNAP CAR platform technology as a "universal" CAR therapy with the potential to target multiple antigens through combinatorial use of different adaptorsWEXFORD, Pa., Oct. 31, 2023 /PRNewswire/ -- ...
<p style="TEXT-ALIGN:CENTER">Conference Call and Webcast at 8:30AM Eastern TimeNEW YORK, Oct. 31, 2023 /PRNewswire/ -- <a ...
DUBLIN--(BUSINESS WIRE)--Oct 31, 2023--The <a ...
PALO ALTO, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 31, 2023--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and <a ...